SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination

被引：150
|
作者：
Li, Pengfei [1 ]
Wang, Yining [1 ]
Lavrijsen, Marla [1 ]
Lamers, Mart M. [2 ]
de Vries, Annemarie C. [1 ]
Rottier, Robbert J. [3 ,4 ]
Bruno, Marco J. [1 ]
Peppelenbosch, Maikel P. [1 ]
Haagmans, Bart L. [2 ]
Pan, Qiuwei [1 ]
机构：
[1] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Med Ctr, Erasmus MC, Virosci Dept, Rotterdam, Netherlands
[3] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands
[4] Univ Med Ctr, Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands
来源：
CELL RESEARCH | 2022年 / 32卷 / 03期
关键词：
D O I：
10.1038/s41422-022-00618-w
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：322 / 324
页数：3
相关论文
共 50 条
  • [1] SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
    Pengfei Li
    Yining Wang
    Marla Lavrijsen
    Mart M. Lamers
    Annemarie C. de Vries
    Robbert J. Rottier
    Marco J. Bruno
    Maikel P. Peppelenbosch
    Bart L. Haagmans
    Qiuwei Pan
    Cell Research, 2022, 32 : 322 - 324
  • [2] Omicron: A highly transmissible SARS-CoV-2 variant
    Rahimi, Farid
    Abadi, Amin Talebi Bezmin
    GENE REPORTS, 2022, 27
  • [3] Omicron: A highly transmissible SARS-CoV-2 variant
    Rahimi, Farid
    Abadi, Amin Talebi Bezmin
    GENE REPORTS, 2022, 27
  • [4] Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
    Jeong, Ju Hwan
    Chokkakula, Santosh
    Min, Seong Cheol
    Kim, Beom Kyu
    Choi, Won-Suk
    Oh, Sol
    Yun, Yu Soo
    Kang, Da Hyeon
    Lee, Ok-Jun
    Kim, Eung-Gook
    Choi, Jang-Hoon
    Lee, Joo-Yeon
    Choi, Young Ki
    Baek, Yun Hee
    Song, Min-Suk
    ANTIVIRAL RESEARCH, 2022, 208
  • [5] SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
    Denisa Bojkova
    Tamara Rothenburger
    Sandra Ciesek
    Mark N. Wass
    Martin Michaelis
    Jindrich Cinatl
    Cell Discovery, 8
  • [6] SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
    Bojkova, Denisa
    Rothenburger, Tamara
    Ciesek, Sandra
    Wass, Mark N.
    Michaelis, Martin
    Cinatl, Jindrich, Jr.
    CELL DISCOVERY, 2022, 8 (01)
  • [7] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
    Vangeel, Laura
    Chiu, Winston
    De Jonghe, Steven
    Maes, Piet
    Slechten, Bram
    Raymenants, Joren
    Andre, Emmanuel
    Leyssen, Pieter
    Neyts, Johan
    Jochmans, Dirk
    ANTIVIRAL RESEARCH, 2022, 198
  • [8] Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2
    Mattiuzzi, C.
    Lippi, G.
    Nocini, R.
    PUBLIC HEALTH, 2022, 206 : E2 - E2
  • [9] Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
    Lee, Byung Uk
    AEROSOL AND AIR QUALITY RESEARCH, 2022, 22 (01)
  • [10] Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants
    Rosales, Romel
    McGovern, Briana L.
    Rodriguez, M. Luis
    Leiva-Rebollo, Rocio
    Diaz-Tapia, Randy
    Benjamin, Jared
    Rai, Devendra K.
    Cardin, Rhonda D.
    Anderson, Annaliesa S.
    Sordillo, Emilia Mia
    van Bakel, Harm
    Simon, Viviana
    Garcia-Sastre, Adolfo
    White, Kris M.
    ANTIVIRAL RESEARCH, 2024, 230
12345